Form S-3 SAB Biotherapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
SAB Biotherapeutics (SABS) files $300M mixed shelf
December 30, 2025 10:11 AM ESTSAB Biotherapeutics (NASDAQ: SABS) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
... More